Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Core EBITDA Growth

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
   Core EBITDA Growth(%) 2.1126.7790.8131.43-

What is the latest Core EBITDA Growth ratio of NATH BIOGENES (INDIA) ?

The latest Core EBITDA Growth ratio of NATH BIOGENES (INDIA) is 2.11 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar20242.11
Mar202326.77
Mar202290.81
Mar201331.43
Mar2012-

How is Core EBITDA Growth of NATH BIOGENES (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 2.11
-92.12
Mar2023 26.77
-70.52
Mar2022 90.81
188.93
Mar2013 31.43
0
Mar2012 0 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Core EBITDA Growth ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹377.2 Cr -2.4% 5.6% -1% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,934.7 Cr -5.8% -6.3% 14.7% Stock Analytics
KAVERI SEED COMPANY ₹6,436.8 Cr -5.7% -15.3% 32.9% Stock Analytics
VENKYS (INDIA) ₹2,264.3 Cr -1.5% 0.4% -16.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,435.5 Cr -2% -1.8% -33.7% Stock Analytics
INDO US BIOTECH ₹307.9 Cr 1.5% 1.6% -27% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-2.4%

5.6%

-1%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses